tuberculosis | CMAC

tuberculosis

Assessment of bactericidal effect of volume-porous composite materials impregnated with silver on Mycobacterium tuberculosis

Objective. Determination of the antimycobacterial efficacy of a composite material impregnated with silver in relation to M. tuberculosis. Materials and Methods. Samples of the outer shell of bulk porous composite materials with antimycobacterial substances included in the structure (silver (Ag) nanoparticles, as well as silver proteinate) were obtained at the Kurchatov Institute. In total, two types of samples with different particle contents were obtained: chitosan Ag and chitosan Ag2. To obtain an outer shell with an impregnated silver proteinate complex from chitosan Primex 43040 with glutaraldehyde: an aqueous solution of silver proteinate with different concentrations («chitosan Pr» and «chitosan Pr2») was added.

Antimicrobial resistance of Mycobacterium tuberculosis clinical isolates from patients with tuberculous spondylitis

Objective. To conduct a comparative evaluation of the results of phenotypic and molecular genetic methods for testing drug resistance of Mycobacterium tuberculosis isolated from bone biopsies of patients with tuberculous spondylitis. Materials and Methods. A retrospective cohort study was conducted on the case histories of patients diagnosed with tuberculous spondylitis who underwent surgical treatment in the period from 2016 to 2021. The main study subject was surgical material. Antimicrobial resistance patterns of MBT isolates was performed using phenotypic and molecular genetic methods.

New regimens and new medications in the treatment of tuberculosis: keeping step?

Rapid tests detecting Mycobacterium tuberculosis and drug resistance which are universally implemented in medical practice has dramatically improved the diagnosis of rifampicin-resistant tuberculosis and shortened turnaround time thus enabling early …

A Clinical Case of Acute Herpesvirus and Pneumocystis Co-infection in a Patient with Progressive Pulmonary Tuberculosis

This article describes a clinical case of fatal polymicrobial pneumonia in a patient with progressive pulmonary tuberculosis. The clinical case represents a co-infection with tuberculosis, viral and pneumocystis infection in a HIV-uninfected patient …

Nonclinical and Clinical Studies of the New Anti-Tuberculosis Drug «Perchlozone®»

This article describes clinical development stages for the novel anti-TB drug «Perchlozone®», which has been approved in Russian Federation in 2012. Based on the phase I–III clinical studies results, efficacy and safety of the drug were assessed, and …

Bacteriological and Molecular Diagnosis of Bacteremia in HIV-positive Patients

The study aimed to compare efficacy of microbiologic and molecular genetic methods in identification of an infectious agent in blood samples from HIV-positive patients with septic symptoms. 130 venous blood samples were studied using microbiological …